Chloroxoquinoline
Chloroxoquinoline is an anticancer agent. Chloroxoquinoline damages the DNA templates of cancer cells, inducing DNA breaks and cell death, and inhibits cell invasion via down-regulating Rho/Rho kinase signaling pathway. Chloroxoquinoline enhances the radiation sensitivity of Lewis lung cancer cells and xenograft tumors in tumor-bearing mouse models but decreases efficacy after long term exposure in rat models by auto-induction effects on CYP1A and CYP3A. Chloroxoquinoline has a broad-spectrum anticancer activity, such as non-small-cell lung carcinoma (NSCLC), breast cancer and gastric cancer[1].
Product Specifications
CAS Number
23833-97-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Cytochrome P450; DNA/RNA Synthesis; ROCK
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Cancer
Smiles
O=C1C=CNC2=C1C=CC(Cl)=C2
Molecular Formula
C9H6ClNO
Molecular Weight
179.60
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3529), CF594 conjugate, 0.1mg/mL
![5-Chloro-6-[4-(ethoxycarbonyl)piperidino]-nicotinic acid](https://cdn.genprice.uk/products/572/6865711754651/imageurl/trc-c031810-10g.webp)